XEOMIN® – The BOTOX® Alternative

Xeomin® is an additive-free formulation of Botulinum Toxin Type A, the same active ingredient found in BOTOX® Cosmetic and Dysport.

However, unlike Botox and Dysport, Xeomin is pure Botulinum Toxin Type A and is completely additive-free. This not only reduces its risk of allergic reaction, but may lessen a patient’s likelihood of forming antibodies in response to the injection, which can increase efficacy. Another key difference is that Xeomin does not require refrigeration or special handling, which allows for a reduction in associated fees. Xeomin is able to be offered at a significantly lower price per unit than both Botox and Dysport.

How Does Xeomin Work?

Xeomin works by inhibiting motor nerve impulses from activating these muscles, allowing the skin above it to relax, and thereby reducing the appearance of wrinkles. In addition to correcting glabellar lines, Dr. Mishkin uses Xeomin to lift and shape the brow, and to reduce the appearance of forehead lines, crow’s feet, “smoker’s lines”, under-eye lines, “bunny lines,” chin dimples, and wrinkling on the neck.

Xeomin is a simple, inpatient procedure using only local anesthesia. The entire procedure typically takes less than 15 minutes and involves only minimal discomfort, and patients can return to work or daily activities immediately after. Full results will be visible between 3-7 days after injection, and typically last between 3-6 months. Like Botox and Dysport, results can actually improve over time with repeated injections, as the muscle becomes conditioned to being relaxed.

Please contact our Fort Lauderdale office or call 954-202-7899 today to schedule your Xeomin consultation. Dr. David Mishkin serves patients in and around Fort Lauderdale, Florida.

Frequently Asked Questions

XEOMIN® (incobotulinumtoxinA) for injection, for intramuscular use, was proven effective in two randomized, double-blind, multicenter, placebo-controlled clinical trials of more than 540 adult patients in the treatment of glabellar frown lines. The average age of patients in the study was 46 years. Patients received 20 Units of XEOMIN® and were classified as responders if they had a 2-grade improvement on a 4-point scale as assessed by the physician and patient. Using these criteria, treatment success was higher with XEOMIN® than placebo on day 30 in both studies (60% and 48% vs. 0% for placebo in both studies). Based on these trials, XEOMIN® received FDA approval for aesthetic use in 2011.

If you are an adult with moderate to severe glabellar lines (frown lines between the eyes), XEOMIN® may be right for you. Talk to your doctor to discuss the benefits and risks of treatment.

Do not take XEOMIN® if you are allergic to botulinum toxin or any of the other ingredients in XEOMIN®. You should also not take XEOMIN® if you have had an allergic reaction to any other botulinum toxin product or have a skin infection at the planned injection site.

During treatment, which usually takes about 10-20 minutes, your doctor will inject XEOMIN® (incobotulinumtoxinA) for injection, for intramuscular use, into the muscles in your forehead that cause frown lines between your brows. No anesthesia is required; however, your physician may use a topical anesthetic or cold pack to reduce any discomfort.

In clinical trials, some patients observed visible smoothing as early as 3-4 days after injection. The median first onset of effect was less than a week. The maximum effect occurred at 30 days. The typical duration of effect was up to 3 months in clinical trials but may last significantly longer or shorter in individual patients.